Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/02/2005EP1589959A2 Methods of treating lower urinary tract disorders using sodium channel modulators
11/02/2005EP1589958A1 Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
11/02/2005EP1589957A1 Pharmaceutical compositions and process of production thereof
11/02/2005EP1589956A2 Transdermal granisetron
11/02/2005EP1589955A2 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
11/02/2005EP1589953A1 Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion
11/02/2005EP1589951A2 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
11/02/2005EP1589950A1 Methods for making pharmaceutical dosage forms containing active cushioning components
11/02/2005EP1589949A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
11/02/2005EP1589948A1 Drug particles obtained by freezing onto a cold surface
11/02/2005EP1589947A2 Pharmaceutical formulation with an insoluble active agent for pulmonary administration
11/02/2005EP1589946A2 Solution for nostril wash
11/02/2005EP1589945A1 Topical pharmaceutical and/or cosmetic dispense systems
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1589931A2 RNAi TARGETING OF VIRUSES
11/02/2005EP1589930A2 Combination therapy for anticoagulation
11/02/2005EP1589834A1 Enteral composition for the prevention and/or treatment of sepsis
11/02/2005EP1589829A2 Dietary foodstuff for positively influencing cardiovascular health
11/02/2005EP1589827A1 Methods and compositions utilizing astaxanthin
11/02/2005EP1589815A2 POLYCOSANOLS FROM i ERICERUS PELA /i WAX
11/02/2005EP1516624A9 Method of producing calcium gluconolactate, compositions, processes and uses of same
11/02/2005EP1513813B1 Opioid receptor antagonists
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1507530B1 Diaminothiazoles and use thereof as cdk4 inhibitors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1482796A4 Stable compositions comprising tezacitabine
11/02/2005EP1472256B1 Piperidine derivatives
11/02/2005EP1450859A4 Methods and compositions for the diagnosis of asthma
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1427415A4 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
11/02/2005EP1425007B1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
11/02/2005EP1421214A4 Amplified oncogenes and their involvement in cancer
11/02/2005EP1392679B1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds
11/02/2005EP1389910A4 Intraoral delivery of nicotine for smoking cessation
11/02/2005EP1383749B1 Arylsulfonamides as antiviral agents
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1373254B1 Process for the preparation of the anti-migraine drug eletriptan
11/02/2005EP1368056B1 Recombinant gelatin-like proteins for use as plasma expanders
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1307227B1 Pharmaceutical compositions
11/02/2005EP1307181B1 Novel compositions of minoxidil
11/02/2005EP1296691B1 Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
11/02/2005EP1292304B1 Zolpidem hemitartrate
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1263503B1 Use of cyanoquinolines for treating or inhibiting colonic polyps
11/02/2005EP1257254B1 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
11/02/2005EP1246826B1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1212039B1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
11/02/2005EP1200320B1 Valve with a two-component seal
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1082092B1 Anti-germ attachment - composition
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1061873B1 Use of glyceraldehyde as corneal hardening agents
11/02/2005EP1059916B1 Extended release dosage form
11/02/2005EP1049686B1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP1012147B1 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
11/02/2005EP1009414B1 Novel pharmaceutical composition comprising clindamycin and clotrimazol for the treatment of vaginal infections
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005EP1004316B1 Therapeutics for diabetic complications
11/02/2005EP0994706B1 Compositions for administering taxanes orally to human patients and their use
11/02/2005EP0963219B1 Manipulations of nitrosative and oxidative stress in the treatment of a disease
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005EP0901521B1 Antigenic modulation of cells
11/02/2005EP0738152B1 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
11/02/2005CN1692161A Treatment for asthma or allergies
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692122A New etonogestrel esters
11/02/2005CN1692116A Adenosine A2A receptor antagonists
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692113A Polysubstituted imidazopyridines as gastric secretion inhibitors
11/02/2005CN1692110A New 3-(4-oxygen-4H-benzopyranyl-2-base)-(1H)-quinoline-4-ketone derivant, its preparing method and drug compositions containing them
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1692105A Cetirizine dihydrochloride polymorph and preparation method thereof
11/02/2005CN1692101A 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
11/02/2005CN1691965A Pharmaceutical composition for controlled release and manufacturing method thereof
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1691954A Extraction of pharmaceutically active cannabinoids from plant materials
11/02/2005CN1691951A Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
11/02/2005CN1691947A Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/02/2005CN1691946A Application of tacrolimus (FK056) derivant united with beta2-excitomotor for treating asthma
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1691943A Cancer treatment with go6976 and its related compounds
11/02/2005CN1691942A Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid
11/02/2005CN1691941A Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
11/02/2005CN1691940A Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue
1 ... 4484 4485 4486 4487 4488 4489 4490 4491 4492 4493 4494 4495 4496 4497 4498 4499 4500 4501 4502 4503 4504 ... 7860